Hillhouse-backed Genor Biopharma files for $320m HK IPO

Hillhouse-backed Chinese biopharmaceutical firm JHBP (CY) Holdings Limited, also known as Genor Biopharma, has filed for an initial public offering (IPO) on the Main Board of the Hong Kong Stock Exchange (HKEX) to raise about HK$2.48 billion ($320 million).